The authors propose that social prescribing should be reviewed as a health and social care strategy to assist patients diagnosed with chronic illness in order to support existing traditional bio-medical treatments so that individuals receive a holistic care package that will create improvements in their health and well-being. Whilst, social prescribing strategies have been developed within western healthcare systems for over twenty years and are again, receiving renewed interest, there has been little evidence of its use within the MENA region. This Middle East region has pre-dominantly continued to utilize pharmaceutical interventions for patients with chronic illness. Post-COVID-19 healthcare providers continue to look for innovative strategies within a global economic downturn crisis whilst also looking to address the detrimental effects on the treatments of chronic illnesses. The use of social prescribing utilizes psychological and social factors rather than an overreliance on the bio-medical model which relies on biological interventions to chronic illnesses. Firstly, the authors recommend for the of social prescribing in order to create a holistic approach to combating the health and social care determinants of those diagnosed with chronic illness within the Middle Eastern region. This paper will conduct a scoping review of health models and present three models that demonstrate how the use of social prescribing could be used encourage a self-management approach as a means of aiding patients to become more independent of in-patient care and current medically led interventions. Secondly, the authors will highlight three health models to demonstrate the theoretical evidence base of how social prescribing could be aligned with a health strategy to treat chronic illness in the Middle East.